CDRE

Cadre Holdings Inc

Add to Watchlist

Advanced Chart

42.460

0(0.000%)1D

Line

Candle

YTD

High

42.620

Open

42.620

VWAP

42.31

Vol

381.50K

Mkt Cap

1.73B

Low

41.360

Amount

16.14M

EV/EBITDA(TTM)

22.08

Total Shares

40.61M

1.91B

EV/OCF(TTM)

49.57

P/S(TTM)

3.04

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

FY2026Q1

159.23M

+45.54%

0.322

+257.41%

180.92M

+2.81%

0.434

+35.72%

160.27M

+23.19%

0.273

+18.84%

Estimates Revision

The market is revising Upward the revenue expectations for Cadre Holdings, Inc. (CDRE) for FY2025, with the revenue forecasts being adjusted by 0.01% over the past three months. During the same period, the stock price has changed by 28.39%.

Revenue Estimates for FY2025

Revise Upward

+0.01%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+1.86%

In Past 3 Month

Stock Price

Go Up

+28.39%

In Past 3 Month

5 Analyst Rating

-0.14% Downside

Wall Street analysts forecast CDRE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CDRE is 42.40 USD with a low forecast of 26.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

0 Hold

1 Sell

Moderate Buy

-0.14% Downside

Current: 42.460

Low

26.00

Averages

42.40

High

50.00

-0.14% Downside

Current: 42.460

Low

26.00

Averages

42.40

High

50.00

BofA

Ronald Epstein

Neutral -> Underperform

downgrade

$38 -> $26

2025-08-13

Reason

BofA

Ronald Epstein

Price Target

$38 -> $26

2025-08-13

downgrade

Neutral -> Underperform

Reason

BofA analyst Ronald Epstein downgraded Cadre to Underperform from Neutral with a price target of $26, down from $38.

BofA

Neutral -> Underperform

downgrade

$38 -> $26

2025-08-13

Reason

BofA

Price Target

$38 -> $26

2025-08-13

downgrade

Neutral -> Underperform

Reason

As previously reported, BofA downgraded Cadre to Underperform from Neutral with a price target of $26, down from $38. Since the company's Q2 report, the firm's concerns about slow growth and the current M&A environment have not abated, the analyst tells investors. Given the 1% decline in organic growth in Q2 and management noting several contracts delays, the firm see the potential for further pressure in the second half of 2025, the analyst added.

BofA

Buy -> Neutral

downgrade

$38

2025-06-13

Reason

BofA

Price Target

$38

2025-06-13

downgrade

Buy -> Neutral

Reason

BofA downgraded Cadre to Neutral from Buy with a $38 price target.

BofA

Ronald Epstein

Buy -> Neutral

downgrade

$45 -> $38

2025-06-13

Reason

BofA

Ronald Epstein

Price Target

$45 -> $38

2025-06-13

downgrade

Buy -> Neutral

Reason

B. Riley

Buy

maintain

$48 -> $50

2025-05-08

Reason

B. Riley

Price Target

$48 -> $50

2025-05-08

maintain

Buy

Reason

Roth MKM

Matt Koranda

Strong Buy

Maintains

$39 → $37

2024-11-07

Reason

Roth MKM

Matt Koranda

Price Target

$39 → $37

2024-11-07

Maintains

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Cadre Holdings Inc (CDRE.N) is 31.97, compared to its 5-year average forward P/E of 31.45. For a more detailed relative valuation and DCF analysis to assess Cadre Holdings Inc 's fair value, click here.

Forward PE
Forward EV/EBITDA
Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

31.45

Current PE

31.97

Overvalued PE

48.98

Undervalued PE

13.93

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Strongly Overvalued

5Y Average EV/EBITDA

12.70

Current EV/EBITDA

15.34

Overvalued EV/EBITDA

13.95

Undervalued EV/EBITDA

11.45

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

2.23

Current PS

42.46

Overvalued PS

5.14

Undervalued PS

-0.67